Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia

Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia

BackgroundPlasma biomarkers are preferable to invasive and expensive diagnostic tools, such as neuroimaging and lumbar puncture that are gold standard in the clinical management of Alzheimer’s Disease (AD). Here, we investigated plasma Glial Fibrillary Acidic Protein (GFAP), Neurofilament Light Chai...

Full description

Bibliographic Details
Main Authors: Assunta Ingannato, Silvia Bagnoli, Salvatore Mazzeo, Giulia Giacomucci, Valentina Bessi, Camilla Ferrari, Sandro Sorbi, Benedetta Nacmias
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Endocrinology
Subjects:
Alzheimer's disease
preclinical stages
plasma biomarkers
glial fibrillary acidic protein
neurofilament light chain
phosphorylated-tau-181
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1375302/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2024.1375302/full

Similar Items